Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC) - Concepedia

Concepedia

Publication | Open Access

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)

DOI Full Paper Access

13

Citations

38

References

2017

Year

Mitchell E. Gross, Tanya B. Dorff, David I. Quinn, Patricia Diaz, Olga Castellanos, David B. Agus

Clinical Genitourinary Cancer

UrologyOncologyGenitourinary CancerMedicinePharmacotherapyCastration-resistant Prostate CancerCancer TreatmentProstatic DiseasePharmacology

References

	Year	Citations

Page 1